ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19

Abstract A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivate...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zeynab Fakhar, Shama Khan, Suliman Y. AlOmar, Afrah Alkhuriji, Aijaz Ahmad
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/56fdadd47ce44b4b95f39f40b4b20e7f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!